Measles

The immune response to measles plays a crucial role in both recovery and long-term protection. The virus primarily infects respiratory epithelial cells and then spreads to lymphoid tissues, where it establishes viremia. Measles-induced immunosuppression contributes to increased susceptibility to secondary infections, posing additional health risks. The rash characteristic of measles results from the immune response and inflammation. MeV infects immune cells, leading to their dissemination throughout the body, and triggers a strong immune reaction. The measles-specific immune response involves the production of antibodies and the activation of T cells, contributing to viral clearance. Measles has a considerable impact on public health, with outbreaks posing challenges to healthcare systems. The virus is highly transmissible, requiring high vaccine coverage for herd immunity to prevent sustained transmission. As a result, efforts to eliminate measles involve strengthening routine immunization programs, conducting supplementary vaccination campaigns, and improving surveillance systems to detect and respond to outbreaks promptly. Global initiatives, such as the Measles & Rubella Initiative, aim to reduce measles-related morbidity and mortality through vaccination campaigns. While progress has been made, challenges such as vaccine hesitancy, logistical barriers, and disruptions due to the COVID-19 pandemic continue to impede measles elimination efforts. Research into the virus's molecular biology, host-pathogen interactions, and improved vaccination strategies remains crucial for advancing our understanding of measles and enhancing preventive measures. The ongoing commitment to global vaccination programs and public health interventions is key to controlling and eventually eradicating measles as a significant public health threat.